Avalo Therapeutics, Inc.
AVTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35,129 | -$31,544 | -$41,658 | -$84,376 |
| Dep. & Amort. | $169 | $158 | $166 | $1,657 |
| Deferred Tax | $114 | $14 | $28 | $22 |
| Stock-Based Comp. | $5,852 | $3,477 | $0 | $8,172 |
| Change in WC | -$4,708 | -$9,240 | -$60 | $2,839 |
| Other Non-Cash | -$15,354 | $6,455 | $14,773 | $794 |
| Operating Cash Flow | -$49,056 | -$30,680 | -$26,751 | -$70,892 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$158 | -$95 | -$113 |
| Net Acquisitions | $356 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $25 | $0 | $0 |
| Investing Cash Flow | $356 | -$133 | -$95 | -$113 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$21,244 | -$14,806 | $32,900 |
| Stock Issued | $115,625 | $46,219 | $107 | $71,929 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $60,224 | $67 | $0 | $1,933 |
| Financing Cash Flow | $175,849 | $25,042 | -$14,699 | $106,762 |
| Forex Effect | $0 | $0 | $96 | $0 |
| Net Chg. in Cash | $127,149 | -$5,771 | -$41,449 | $35,757 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,547 | $13,318 | $54,636 | $19,106 |
| End Cash | $134,696 | $7,547 | $13,187 | $54,863 |
| Free Cash Flow | -$49,056 | -$30,838 | -$26,846 | -$71,005 |